Izarraras, K.; Shah, A.; Prasad, K.; Tan, H.; Zhou, Z.; Bhattacharya, M.
Kisspeptin Mitigates Hepatic De Novo Lipogenesis in Metabolic Dysfunction-Associated Steatotic Liver Disease. Cells 2025, 14, 1289.
https://doi.org/10.3390/cells14161289
AMA Style
Izarraras K, Shah A, Prasad K, Tan H, Zhou Z, Bhattacharya M.
Kisspeptin Mitigates Hepatic De Novo Lipogenesis in Metabolic Dysfunction-Associated Steatotic Liver Disease. Cells. 2025; 14(16):1289.
https://doi.org/10.3390/cells14161289
Chicago/Turabian Style
Izarraras, Kimberly, Ankit Shah, Kavita Prasad, Helena Tan, Zhongren Zhou, and Moshmi Bhattacharya.
2025. "Kisspeptin Mitigates Hepatic De Novo Lipogenesis in Metabolic Dysfunction-Associated Steatotic Liver Disease" Cells 14, no. 16: 1289.
https://doi.org/10.3390/cells14161289
APA Style
Izarraras, K., Shah, A., Prasad, K., Tan, H., Zhou, Z., & Bhattacharya, M.
(2025). Kisspeptin Mitigates Hepatic De Novo Lipogenesis in Metabolic Dysfunction-Associated Steatotic Liver Disease. Cells, 14(16), 1289.
https://doi.org/10.3390/cells14161289